Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study
Authors:
- Grazielle Rosa da Costa e SilvaGSGrazielle Rosa da Costa e Silva
- Winny Éveny Alves MouraWMWinny Éveny Alves Moura
- Kamila Cardoso dos SantosKSKamila Cardoso dos Santos
- Davi Oliveira GomesDGDavi Oliveira Gomes
- Gabriela Nolasco BandeiraGBGabriela Nolasco Bandeira
- Rafael Alves GuimarãesRGRafael Alves Guimarães
- Claci Fátima Weirich RossoCRClaci Fátima Weirich Rosso
- Gabriela Silvério BazilioGBGabriela Silvério Bazilio
- Vanessa Rafaela Milhomem Cruz LeiteVLVanessa Rafaela Milhomem Cruz Leite
- Karlla Antonieta Amorim CaetanoKCKarlla Antonieta Amorim Caetano
- Megmar Aparecida dos Santos CarneiroMCMegmar Aparecida dos Santos Carneiro
- Sheila Araújo TelesSTSheila Araújo Teles
Open Access
- 13 January 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (2) , 1483
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has changed the course of human history and killed millions of people worldwide. Its long-term consequences remain uncertain. This study aimed to describe the short- and long-term symptoms of COVID-19 among individuals in Goiás, central Brazil, who experienced acute mild or non-symptomatic SARS-CoV-2 infection during the first wave of the pandemic. This prospective cohort study included 110 healthcare workers, 18 safety workers, and 19 administrative support workers, who were followed up for 12 months after the onset of COVID-19. Most participants were healthy adult female healthcare professionals. At the onset of infection, the major symptoms were headache, myalgia, nasal congestion, cough, coryza, anosmia, ageusia, sore throat, fatigue, diarrhea, and dyspnea. Furthermore, 20.3% of the participants had three or more COVID-19 symptoms that persisted for at least 12 months. These included coryza, congestion, hair loss, sore throat, headache, myalgia, cough, memory loss, anosmia, and fatigue. This study revealed a high prevalence of persistent symptoms of COVID-19 in healthy individuals from central Brazil, which may present an additional burden on healthcare services. Further studies are required to investigate the sequelae of COVID-19 over periods greater than 12 months.Keywords
Funding Information
- Brazilian National Council for Scientific and Technological Development (#402970/2021-7)
This publication has 37 references indexed in Scilit:
- Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targetingEuropean Journal of Pharmacology, 2020
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysisReviews in Medical Virology, 2020
- Persistent Symptoms in Patients After Acute COVID-19JAMA, 2020
- A comprehensive review of COVID-19 characteristicsBiological Procedures Online, 2020
- Cerebral Micro-Structural Changes in COVID-19 Patients – An MRI-based 3-month Follow-up StudyeClinicalMedicine, 2020
- Drug treatments for covid-19: living systematic review and network meta-analysisBMJ, 2020
- Organ-specific manifestations of COVID-19 infectionClinical and Experimental Medicine, 2020
- The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 InfectionsJournal of Neuroimmune Pharmacology, 2020
- Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)Journal of Microbiology and Biotechnology, 2020
- Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysisTravel Medicine and Infectious Disease, 2020